Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings

OBJECTIVES: Our objectives were to investigate the cost effectiveness of apixaban, rivaroxaban, and dabigatran compared with coumarin derivatives for stroke prevention in patients with atrial fibrillation in a country with specialized anticoagulation clinics (the Netherlands) and in a country withou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Cardiovasc Drugs
Egile Nagusiak: Verhoef, Talitha I., Redekop, William K., Hasrat, Fazila, de Boer, Anthonius, Maitland-van der Zee, Anke Hilse
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2014
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250561/
https://ncbi.nlm.nih.gov/pubmed/25326294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-014-0092-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak